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Background: The management of the moderate and severe forms of acute pancreatitis
(AP) with necrosis and multiorgan failure remains a challenge. To predict the severity
and mortality of AP multiple clinical, laboratory-, and imaging-based scoring systems
are available.
Aim: To investigate, if the computed tomography severity index (CTSI) can predict the
outcomes of AP better than other scoring systems.
Methods: A systematic search was performed in three databases: Pubmed, Embase,
and the Cochrane Library. Eligible records provided data from consecutive AP cases and
used CTSI or modified CTSI (mCTSI) alone or in combination with other prognostic scores
[Ranson, bedside index of severity in acute pancreatitis (BISAP), Acute Physiology, and
Chronic Health Examination II (APACHE II), C-reactive protein (CRP)] for the evaluation of
severity or mortality of AP. Area under the curves (AUCs) with 95% confidence intervals
(CIs) were calculated and aggregated with STATA 14 software using the metandi module.
Results: Altogether, 30 studies were included in our meta-analysis, which contained
the data of 5,988 AP cases. The pooled AUC for the prediction of mortality was 0.79
(CI 0.73–0.86) for CTSI; 0.87 (CI 0.83–0.90) for BISAP; 0.80 (CI 0.72–0.89) for mCTSI;
0.73 (CI 0.66–0.81) for CRP level; 0.87 (CI 0.81–0.92) for the Ranson score; and 0.91
(CI 0.88–0.93) for the APACHE II score. The APACHE II scoring system had significantly
higher predictive value for mortality than CTSI and CRP (p = 0.001 and p < 0.001,
respectively), while the predictive value of CTSI was not statistically different from that
of BISAP, mCTSI, CRP, or Ranson criteria. The AUC for the prediction of severity of AP
were 0.80 (CI 0.76–0.85) for CTSI; 0.79, (CI 0.72–0.86) for BISAP; 0.83 (CI 0.75–0.91)
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for mCTSI; 0.73 (CI 0.64–0.83) for CRP level; 0.81 (CI 0.75–0.87) for Ranson score and
0.80 (CI 0.77–0.83) for APACHE II score. Regarding severity, all tools performed equally.
Conclusion: Though APACHE II is the most accurate predictor of mortality, CTSI is a
good predictor of both mortality and AP severity. When the CT scan has been performed,
CTSI is an easily calculable and informative tool, which should be used more often in
routine clinical practice.
Keywords: acute pancreatitis, CT-severity index, accuracy, severity, mortality
INTRODUCTION
Rationale
Acute pancreatitis (AP) is an inflammatory disease of the
pancreas, one of the most common causes of hospitalization
among gastrointestinal diseases (Lankisch et al., 2015). Based
on the revised Atlanta classification, the severity of AP may
be mild, moderate, or severe (Banks et al., 2013). Most cases
of AP are mild, but the management of the moderate and
severe forms of the disease with necrosis and multiorgan failure
remains a challenge. The prognosis of the severe form is poor, it
occurs in 8.8% of AP (Parniczky et al., 2016) and the mortality
of severe AP (SAP) may reach 28% (Parniczky et al., 2016).
Therefore, it is necessary to predict the severity of the disease
because the early escalation of care and aggressive therapy may
prevent complications and adverse outcomes of AP in high-risk
patients. Unfortunately, research on pancreatitis is in danger,
therefore, attempts to obtain clinically relevant data has very high
importance (Szentesi et al., 2016).
Objectives
Currently, there are various scoring systems used for the early
prediction of SAP. First, the Ranson score was used (Ranson
and Pasternack, 1977), but later the acute physiology and chronic
health examination II (APACHE II) scoring system seemed
to be more accurate (Yeung et al., 2006). Moreover, several
inflammatory parameters such as C-reactive protein (CRP) and
interleukin-6 were documented to be clinically relevant in the
differentiation of mild and non-mild AP (Sternby et al., 2017).
In 2008, a new, easy-to-implement bedside index of severity
in acute pancreatitis (BISAP) was proposed for use within
24 h of hospitalization to predict in-hospital mortality (Wu
et al., 2008). However, with the improvements of the imaging
techniques, contrast-enhanced computed tomography (CT) gets
an important place in the diagnosis of AP and its complications.
In the early ‘90s, Balthazar and his coworkers developed a
numerical scoring system, the CT severity index (CTSI), for
the estimation of the severity of AP (Balthazar et al., 1990).
It combines the quantification of pancreatic and peripancreatic
inflammation with the extent of pancreatic parenchymal
necrosis. In 2004, Mortele et al., formulated the modified CTSI
(mCTSI) including a simplified evaluation of peripancreatic
inflammation and extent of pancreatic parenchymal necrosis
and incorporated the extrapancreatic complications (vascular,
gastrointestinal, and extrapancreatic parenchymal complications
as well as the presence of pleural effusion and/or ascites) in
the assessment. This modified index correlated more with the
outcome of AP (Mortele et al., 2004). Tables 1A,B show the
components of CTSI and mCTSI.
Research Question
It is still not clear, which scoring system has the highest predictive
accuracy for severity and mortality of AP. The aim of this
meta-analysis was to investigate, how accurate CT-based severity
indices are in the prediction of the severity andmortality of AP in
comparison with other widely accepted and used scoring systems.
TABLE 1 | Components of the CTSI and mCTSI.
(A) Components of the CTSI
Pancreatic inflammation
Normal pancreas 0
Focal or diffuse enlargement of the pancreas 1
Intrinsic pancreatic abnormalities with inflammatory changes in
peripancreatic fat
2
Single, ill-defined fluid collection or phlegmon 3
Two or more poorly defined collections or presence of gas in or
adjacent to the pancreas
4
Pancreatic necrosis
None 0
≤30% 2
>30% and ≤50% 4
>50% 6
(B) Components of the mCTSI
Pancreatic inflammation
Normal pancreas 0
Intrinsic pancreatic abnormalities with peripancreatic inflammatory
changes
2
Pancreatic or peripancreatic fluid collection or peripancreatic fat
necrosis
4
Pancreatic necrosis
None 0
Less 30% 2
>30% 4
Extrapancreatic complications
Pleural effusion, ascites, vascular complication (venous
thrombosis, arterial hemorrhage, pseudoaneurysm), parenchymal
complication (infarction, hemorrhage, subcapsular fluid collection),
GI involvement (inflammation, perforation, intraluminal fluid
collection)
2
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METHODS
Study Design, Participants, Interventions,
Comparators
The systematic search was conducted according to the
Preferred Reporting Items for Systematic Reviews and
Meta-Analyses (PRISMA) Statement (Moher et al., 2009)
(Supplementary Document 1). We included studies on AP that
used CTSI or mCTSI (index test) and compared them to any of
the other scoring systems (Ranson, BISAP, APACHE II) or CRP
(reference standards) in terms of their predictive value.
Search Strategy
A systematic search was performed in Pubmed, Embase, and
the Cochrane Library (CENTRAL), using the following search
query: “acute pancreatitis” AND (“computed tomography severity
index” OR CTSI OR “modified computed tomography severity
index” OR MCTSI). English language filter was used. Search key
in Embase were: (‘acute pancreatitis’/exp OR ‘acute pancreatitis’)
AND (ctsi OR mctsi OR ‘computed tomography severity index’/exp
OR ‘computed tomography severity index’ OR ‘modified computed
tomography severity index’) AND [english]/lim. The search was
conducted on 11th March 2018. Duplicates were removed using
the (EndNote X7.4, Clarivate Analytics, Philadelphia, PA, US)
reference manager software.
Study Selection and Data Extraction
Two independent investigators (EV, AM) selected the studies,
and disagreements were resolved by a third reviewer (PH). The
records were selected for meta-analysis if (1) AP patients of any
severity were enrolled consecutively; (2) if CTSI or mCTSI were
used for the prediction of the severity or mortality of AP; and
(3) if sensitivity and specificity values, the absolute numbers of
true positive (TP), false negative (FN), false positive (FP) and true
negative (TN), and/or area under the curve (AUC) were reported
(for CTSI/mCTSI regarding AP severity and/or mortality). If
other prognostic scores (Ranson, BISAP, APACHE II) or CRP
values were also assessed in the selected articles, those results
were extracted as well. Only full-text articles were included.
Studies, which met the inclusion criteria were assessed for
full-text evaluation. The following data were extracted from the
articles: first author; year of the publication; study period; study
design; the AP scoring systems used; evaluation time of the
scores; the used definition for SAP; sample size based on severity;
mean age; male/female ratio; cut-off value, clinical end-points,
FIGURE 1 | Flowchart of study selection.
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TABLE 2 | Basic characteristics of the included studies.
Study
number
References Study period Study
design
Country Groups Evaluation
time, h
Definition of
SAP
Sample size Age Male/female
ratio
Severity Mortality
1 Cho et al., 2015 2011–2012 Prospective South Korea CTSI <48 of
admission
2012 revised
Atlanta
161 62.3a ±
16.1c
102/59 +
Ranson <48 of
admission
BISAP <24 of
admission
APACHE II <24 of
admission
CRP On admission
and 24 h after
admission
2 Gurleyik et al.,
2005
2001–2005 Prospective Turkey CTSI <120 after
the onset of
symptoms
1992 Atlanta 55 Mild: 56.1a
(28–98)e
severe: 60.3a
(23–77)e
18/37 +
APACHE II 48
CRP at 48 h
3 Lee et al., 2016 2010–2013 Prospective South Korea CTSI On admission 2012 revised
Atlanta
146 Mild: 48.8a ±
16.4c,
moderate:
49.3a ±
18.5c, severe:
63a ± 22.8c
92/54 +
Ranson On admission
BISAP On admission
APACHE II On admission
CRP On admission
and 24 h after
admission
4 Qiu et al., 2015 2008–2014 Retrospective China CTSI <48 h of
admission
2012 revised
Atlanta
129 57a ± 17.3c 468/441 +
Ranson <48 h of
admission
BISAP <24 h of
admission
CTSI <48 h of
admission
780
Ranson <48 h of
admission
BISAP <24 h of
admission
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TABLE 2 | Continued
Study
number
References Study period Study
design
Country Groups Evaluation
time, h
Definition of
SAP
Sample size Age Male/female
ratio
Severity Mortality
5 Yue et al., 2015 2011–2013 Prospective China CTSI <48 h of
admission
2009 Atlanta 169 54.3a ±
16.7c
98/71 +
Ranson <48 h
APACHE II 0., and 72 h
6 Biberoglu et al.,
2017
2010–2011 Retropsective Turkey CTSI NA NA 76 Presented in
intervals
29/47 +
7 Bollen et al., 2011 2005–2007 Prospective NA CTSI 0–168 h,
median 48 h
after onset of
symptoms
2009 Atlanta 196 53a (21–94)e 107/89 + +
MCTSI 0–168 h,
median 48 h
after onset of
symptoms
APACHE II NA
8 Sharma et al.,
2015
2013–2014 Retropsective India CTSI 72–240 h
after onset of
symptoms
2012 revised
Atlanta
105 40.6a ±
12.99NA
65/40 +
MCTSI 72–240 h
after onset of
symptoms
BISAP NA
9 Yang et al., 2016 2007–2015 Retropsective China MCTSI <72 after
onset of
symptoms
2008 Atlanta 326 44a (14–85)e 184/142 + +
BISAP <24 of
admission
Ranson <48 of
admission
APACHE II <24 of
admission
10 Bollen et al., 2012 2.5 year
period
Prospective USA CTSI <24 of
admission
2009 Atlanta 131 54b (21–91)e 84/66 + +
MCTSI <24 of
admission
131
APACHE II NA 131/159
BISAP NA 131/159
11 Alper et al., 2016 2011–2014 Prospective Turkey CTSI Within
72–96 h after
admission
CTSI >6
and/or
modified
Glasgow
score >3
187 mild 57a ±
17.9NA,
severe
60.1a ±
15.9NA
111/76 + +
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TABLE 2 | Continued
Study
number
References Study period Study
design
Country Groups Evaluation
time, h
Definition of
SAP
Sample size Age Male/female
ratio
Severity Mortality
12 Zhao et al., 2016 2012–2014 Observational China APACHE II At admission
= <72 h after
onset of
symptoms
2012 revised
Atlanta
74 NA NA +
CTSI At admission
= <72 h after
onset of
symptoms
CRP <72 h
13 Fabre et al., 2012 2003–2007 Retrospective France Ranson NA 1992 Atlanta 48 133 monthsb
(24.9–233.5)e
23/25 +
CTSI 17
14 Simchuk et al.,
2000
1992–1997 Retrospective USA CTSI – – 268 57a (18–93)e 147/121 +
15 Jakchairoongruang
and Arjhansiri,
2013
2005–2010 Retrospective Thailand CTSI – – 72 47.7a (6–89)e 39/33 +
16 Hashimoto et al.,
2016
2002–2012 Retrospective Japan Ranson NA DeBanto et al. 37 6b (5–12)e 15/22 +
CTSI 33
17 Park et al., 2013 2007–2010 Retrospective Korea BISAP <24 of
admission
Based on
organ failure
and/or local
complications
303 52NA ± 17NA 216/87 + +
Ranson <48 of
admission
APACHE II <24 of
admission
CTSI Within 7 days
of admission
CRP Initial
CRP After 48 h
18 Khanna et al.,
2013
2010–2012 Prospective India BISAP <24 of
admission
Presence of
organ failure
for more than
48 h and local
complications
72 40.5a
(18–76)e
37/35 + +
APACHE II <24 of
admission
72
Ranson <48 of
admission
72
CTSI On day 4 54
CRP On day 2 60
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TABLE 2 | Continued
Study
number
References Study period Study
design
Country Groups Evaluation
time, h
Definition of
SAP
Sample size Age Male/female
ratio
Severity Mortality
19 Lautz et al., 2012 2000–2009 Retrospective USA CTSI At
presentation
DeBanto et al. 64 12.3b NA +
Ranson NA 64
20 Chatzicostas
et al., 2003
1999–2001 Prospective Greece CTSI <72 h after
admission
(median time
62 h)
1992 Atlanta 78 63.8a
(25–93)e
42/36 +
APACHE II <24 of
admission
Ranson <48 of
admission
21 Xu et al., 2014 2012 Retropsective China CTSI Within 3–5
days after
admission
2008 Atlanta 257 51.2a ±
12.3NA
(23–89)e
196/61 +
22 Yadav et al., 2016 2012–2014 Prospective India BISAP <24 of
admission
Persistent
organ failure
for more than
48 h
119 38.94a ±
14.59c
84/35 + +
Ranson <48 of
admission
CTSI Within the first
7 days of
hospitalization
23 Papachristou
et al., 2010
2003–2007 Prospective USA BISAP <24 of
admission
Presence of
organ failure
for more than
48 h
185 51.7a(15–
90)e
94/91 + +
Ranson <48 of
admission
APACHE II <24 of
admission
CTSI Within 48 h
from
admission
24 Vriens et al., 2005 1994–2002 Prospective Netherlands CTSI Within 48 h
after
admission,
80% within
12 h
NA 79 61a (15–86)e 39/40 +
Ranson <48 of
admission
25 Raghuwanshi
et al., 2016
2013–2015 Prospective India CTSI NA 2012 revised
Atlanta
50 NA NA +
MCTSI
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TABLE 2 | Continued
Study
number
References Study period Study
design
Country Groups Evaluation
time, h
Definition of
SAP
Sample size Age Male/female
ratio
Severity Mortality
26 Banday et al.,
2015
2012–2013 Prospective India MCTSI NA NA 50 42,32a
(17–80)e
33/17 +
27 Huang et al.,
2010
2007–2009 Prospective China CTSI <24 h after
onset of
symptoms
1992 Atlanta 187 Mild: 60.4a ±
6.7c severe:
59.5a ± 7.1c,
112/75 +
28/A Fei et al., 2018 2013–2016 Retrospective China BISAP On admission 2012 revised
Atlanta
1073 47.3a ± 7.1c 615/458 +
CTSI
AAPCHE II
Ranson
28/B 2012–2016 BISAP 326 53.6a ± 8.7c 168/158
CTSI
APACHE II
Ranson
29 Kumar et al.,
2017
2014–2016 Prospective Nepal CTSI After 48 h
after arrival to
hospital
Atlanta 125 46.78a ±
14.16c
74/51 +
CRP at 48 h
Ranson After 48 h of
admission
30 Sahu et al., 2017 2014–2016 Prospective India CTSI Median of 6
days; range
of 5–11 days
2012 revised
Atlanta
60 37a (19–65)e 36/24 +
mCTSI Median of 6
days; range
of 5–11 days
CTSI, computed tomography severity index; MCTSI, modified computed tomography severity index; BISAP, bedside index of severity in acute pancreatitis; APACHE II, Acute Physiology And Chronic Health Examination II; N/A, not
applicable; amean; bmedian; cstandard difference; dstandard error of mean; erange.
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FIGURE 2 | Area under the curve (AUC) summarizing the predictive performance of scoring systems regarding mortality in acute pancreatitis. Size of squares for
effect size reflects weight of studies in pooled analysis. Horizontal bars represent 95% confidence intervals (CI). CTSI, computed tomography severity index; BISAP,
bedside index of severity in acute pancreatitis; mCTSI, modified computed tomography severity index; CRP, C-reactive protein; APACHE II, Acute Physiology And
Chronic Health Examination II. The vertical line represents the line of no effect.
and several data about the statistical analysis were reviewed for
the risk of bias assessment.
Data Analysis
To construct 2 × 2 contingency tables, true positive, false
positive, false negative, and true negative values were
abstracted. These served as input to fit Hierarchial Summary
Receiver Operating Characteristics (HSROC) curves and
estimate summary sensitivity, specificity, and diagnostic odds
ratio (DOR) with 95% confidence intervals (CI). For each
method and outcome, we collected the AUC values and
their CIs as well and performed a meta-analysis using the
random effect model to gain pooled AUC estimates with
95% CI.
The statistical analysis was performed with Stata 14 software
using the metandi module1. Heterogeneity was assessed
using the I2 measure and the corresponding chi2 test, p
< 0.1 indicates significant heterogeneity. Based on the
Cochrane Handbook, I2 = 100% × (Q–df)/Q represents
the magnitude of the heterogeneity (moderate: 30–60%,
1https://www.stata-journal.com/sjpdf.html?articlenum=st0163
Frontiers in Physiology | www.frontiersin.org 9 August 2019 | Volume 10 | Article 1002
Mikó et al. CTSI: Predicting Outcomes in Acute Pancreatitis
substantial: 50–90%, considerable: 75–100%) (Higgins and
Green, 2011).
Risk of Bias and Applicability Assessment
The Predictionmodel Risk Of Bias ASsessment Tool (PROBAST)
(Wolff et al., 2019) was used to assess the risk of bias
and applicability of primary studies in accordance with the
recommendation of the Cochrane Collaboration. This tool is able
to assess the risk of bias based on the following four domains:
participants, predictors, outcome, and analysis. It includes also
concerns regarding applicability in three domains: participants,
predictors and outcome.
RESULTS
Study Selection and Characteristics
The systematic search strategy identified 319 articles after
removal of duplicates. The search provided 123 articles in
Pubmed, 279 studies in Embase and 25 articles in Cochrane
library databases. The flow chart (Figure 1) shows the study
selection process: 148 articles were screened by abstract and
after excluding 86 studies, 62 full-text articles were assessed for
eligibility. A further 32 articles were excluded, because of the
lack of reporting of the outcome of interest or inappropriate
patient population. In ourmeta-analysis 30 articles were included
(Simchuk et al., 2000; Chatzicostas et al., 2003; Gurleyik et al.,
2005; Vriens et al., 2005; Huang et al., 2010; Papachristou et al.,
2010; Bollen et al., 2011, 2012; Fabre et al., 2012; Lautz et al., 2012;
Jakchairoongruang and Arjhansiri, 2013; Khanna et al., 2013;
Park et al., 2013; Xu et al., 2014; Banday et al., 2015; Cho et al.,
2015; Qiu et al., 2015; Sharma et al., 2015; Yue et al., 2015; Alper
et al., 2016; Hashimoto et al., 2016; Lee et al., 2016; Raghuwanshi
et al., 2016; Yadav et al., 2016; Yang et al., 2016; Zhao et al., 2016;
Biberoglu et al., 2017; Kumar et al., 2017; Sahu et al., 2017; Fei
et al., 2018), which contained the data of 5,988 patients. The main
characteristics of the included studies are shown in Table 2.
Prediction of Mortality
From the 30 articles, 11 contained data on AUC for the prediction
of mortality (Figure 2). Table 3 summarizes the study numbers,
sample sizes, AUC, and heterogeneity data of the different
severity scores based on the outcome of AP. For CTSI based on
data from 10 articles, the pooled AUC for mortality was 0.79
(CI 0.73–0.86; heterogeneity I2 = 83%, p < 0.001). Eight articles
included AUC data for mortality for BISAP, the pooled AUC
was 0.87 (CI 0.83–0.90; heterogeneity I2 = 0%, p = 0.578). The
pooled AUC for mCTSI was 0.80 (CI 0.72–0.89; heterogeneity
I2 = 79.4%, p = 0.001) according to five studies. Only two
studies reported AUC data predicting mortality for CRP level,
and the pooled AUC was 0.73 (CI 0.66–0.81; heterogeneity I2
= 0%, p = 0.708) Six articles included AUC data for mortality
for Ranson score with a pooled AUC of 0.87 (CI 0.81–0.92;
heterogeneity I2 = 65.6%, p = 0.013) and also for APACHE II
score with a pooled AUC of 0.91 (CI 0.88–0.93; heterogeneity
I2 = 4.8%, p= 0.386).
TABLE 3 | Summary table of mortality and severity data based on the forest plots.
Score Study
number
Sample
size
AUC (CI) Heterogeneity
MORTALITY
CTSI 10 1,489 0.79 (0.73–0.86) I2 = 83%, p < 0.001
BISAP 8 1,370 0.87 (0.83–0.90) I2 = 0%, p = 0.578
mCTSI 5 818 0.80 (0.72–0.89) I2 = 79.4%, p = 0.001
CRP 2 363 0.73 (0.66–0.81) I2 = 0%, p = 0.708
Ranson 6 1,134 0.87 (0.81–0.92) I2 = 65.6%, p = 0.013
APACHE II 6 1,213 0.91 (0.88–0.93) I2 = 4.8%, p = 0.386
SEVERITY
CTSI 18 2,535 0.80 (0.76–0.85) I2 = 86.2%; p < 0.001
BISAP 10 1,898 0.79 (0.72–0.86) I2 = 89.7%, p < 0.001
mCTSI 3 653 0.83 (0.75–0.91) I2 = 68.1%; p = 0.043
CRP 6 869 0.73 (0.64–0.83) I2 = 77%, p = 0.001
Ranson 14 2,119 0.81 (0.75–0.87) I2 = 87.5%, p < 0.001
APACHE II 11 1,198 0.80 (0.77–0.83) I2 = 36.8%, p = 0.105
Based on the above results of the meta-analytical calculations
the APACHE II scoring system had significantly higher predictive
accuracy for mortality than CTSI or CRP level (p = 0.001; p
< 0.001, respectively). However, CTSI was not different from
the BISAP, mCTSI, CRP or Ranson criteria in the prediction of
mortality of AP, and these scores can be classified as good and fair.
Prediction of Severity
AUC data for severity were included in 19 studies (Figure 3).
The pooled AUC for severity based on data from 18 articles
was 0.80 (CI 0.76–0.85) for CTSI with high heterogeneity (I2 =
86.2%; p < 0.001). The pooled AUC for BISAP was 0.79 (CI
0.72–0.86, heterogeneity I2 = 89.7%, p < 0.001). The pooled
AUC for mCTSI from three studies was 0.83 (CI 0.75–0.91) with
substantial heterogeneity (I2 = 68.1%; p = 0.043). The pooled
AUC was 0.73 (CI 0.64–0.83) for CRP level (heterogeneity:
I2 = 77%, p = 0.001), 0.81 (CI 0.75–0.87) for Ranson score
(heterogeneity I2 = 87.5%, p < 0.001), and 0.80 (CI 0.77–0.83)
for APACHE II score (heterogeneity I2 = 36.8%, p= 0.105).
There was no statistical difference between the severity
predicting values of the different scoring systems. The
heterogeneity values were I2 = 86.2%, p < 0.001; I2 =
89.7%, p < 0.001; I2 = 68.1%, p = 0.043; I2 = 77%, p = 0.001;
I2 = 87.5%, p < 0.001; I2 = 36.8%, p = 0.105 for CTSI, BISAP,
mCTSI, CRP, Ranson, and APACHE II scores, respectively. The
heterogeneity across the studies was significant in all scoring
systems or predicting values, except for the APACHE II score.
Based on the results of the meta-analytical calculations, the
severity prediction values of the included scoring systems are
not different.
HSROC Analysis of Different Scoring
Systems for Predicting Mortality and
Severity of AP
Figure 4A shows the application of CTSI in the form of
HSROC curves for mortality [sensitivity: 0.88 (CI 0.69–0.97);
specificity: 0.61 (CI 0.52–0.70); DOR: 12.84 (CI 4.19–39.41)] and
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FIGURE 3 | Area under the curve (AUC) summarizing the predictive performance of scoring systems regarding severity in acute pancreatitis. Size of squares for effect
size reflects weight of trial in pooled analysis. Horizontal bars represent 95% confidence intervals (CI). CTSI, computed tomography severity index; BISAP, bedside
index of severity in acute pancreatitis; mCTSI, modified computed tomography severity index; CRP, C-reactive protein; APACHE II, Acute Physiology And Chronic
Health Examination II. The vertical line represents the line of no effect.
Figure 4B for severity, respectively [sensitivity: 0.81 (CI 0.73–
0.87); specificity: 0.82 (CI 0.73–0.88); DOR: 19.1 (CI 10.29–
35.45)]. Figure 5A illustrates the bivariate HSROC curve of
BISAP score for mortality [sensitivity: 0.88 (CI 0.71–0.96);
specificity: 0.77 (CI 0.70–0.83); DOR: 24.74 (CI 9.44–64.81)] and
Figure 5B for severity, respectively [sensitivity: 0.73 (CI 0.53–
0.87); specificity: 0.80 (CI 0.72–0.88); DOR: 11.71 (CI 4.49–
30.61)]. Figure 6A shows the application of mCTSI in the form
of HSROC curves for mortality [sensitivity: 0.95 (CI 0.76–
0.99); specificity: 0.36 (CI 0.16–0.63); DOR: 10.32 (CI 2.11–
50.53)] and Figure 6B for severity, respectively [sensitivity: 0.88
(CI 0.47–0.98); specificity: 0.80 (CI 0.56–0.92); DOR: 29.07 (CI
3.36–251.91)]. Figure 7 illustrates the bivariate HSROC curve of
CRP score for severity [sensitivity: 0.71 (CI 0.59–0.81); specificity:
0.87 (CI 0.66–0.96); DOR: 16.75 (CI 3.49–80.48)]. Figure 8A
illustrates the bivariate HSROC curve of Ranson score for
mortality [sensitivity: 0.91 (CI 0.70–0.98); specificity: 0.72 (CI
0.66–0.79); DOR: 28.72 (CI 7.57–109.05)] and Figure 8B for
severity, respectively [sensitivity: 0.79 (CI 0.69–0.86); specificity:
0.78 (CI 0.71–0.84); DOR: 13.32 (CI 7.33–24.24)]. Figure 9A
illustrates the bivariate HSROC curve of APACHE II score
for mortality [sensitivity: 0.92 (CI 0.70–0.98); specificity: 0.79
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TABLE 4 | Summary table of mortality and severity data based on the HSROC
curves.
Score Sensitivity Specificity DOR
MORTALITY
CTSI 0.88 (0.69–0.97) 0.61 (0.52–0.70) 12.84 (4.19–39.41)
BISAP 0.88 (0.71–0.96) 0.77 (0.70–0.83) 24.74 (9.44–64.81)
MCTSI 0.95 (0.76–0.99) 0.36 (0.16–0.63) 10.32 (2.11–50.53)
Ranson 0.91 (0.70–0.98) 0.72 (0.66–0.79) 28.72 (7.57–109.05)
APACHE II 0.92 (0.70–0.98) 0.79 (0.66–0.88) 45.08 (11.4–178.2)
SEVERITY
CTSI 0.81 (0.73–0.87) 0.82 (0.73–0.88) 19.10 (10.29–35.45)
BISAP 0.73 (0.53–0.87) 0.80 (0.72–0.88) 11.71 (4.49–30.61)
MCTSI 0.88 (0.47–0.98) 0.80 (0.56–0.92) 29.07 (3.36–251.91)
CRP 0.71 (0.59–0.81) 0.87 (0.66–0.96) 16.75 (3.49–80.48)
Ranson 0.79 (0.69–0.86) 0.78 (0.71–0.84) 13.32 (7.33–24.24)
APACHE II 0.71 (0.60–0.79) 0.80 (0.71–0.88) 9.94 (6.45–15.30)
(CI 0.66–0.88); DOR: 45.08 (CI 11.4–178.2)] and Figure 9B for
severity, respectively [sensitivity: 0.71 (CI 0.60–0.79); specificity:
0.80 (CI 0.71–0.88); DOR: 9.94 (CI 6.45–15.30)].
Sensitivity, specificity, and DOR data of all scores predicting
mortality and severity are summarized in Table 4. In summary,
the sensitivity for the prediction of mortality of AP was the
highest for mCTSI, Ranson, and APACHE II scores. While the
specificity for prediction of mortality was the best for APACHE
II, BISAP, and Ranson scores. The sensitivity for the prediction
of severity of CTSI, mCTSI, and Ranson scores were the highest,
while the specificity for prediction of severity were the highest for
CRP and CTSI.
Quality Assessment and Risk of Bias
In this study, the two main outcomes were mortality and severity
of the disease, therefore, we included the data in two different
tables. The majority of the studies included in our analysis met
the predefined criteria of the definition of AP and contained
all grades of severities, therefore the risk of bias regarding the
included populations was deemed as low. The data on CTSI from
all studies were significantly limited by the timeframe the CT was
done from either the admission or the onset of the symptoms and
the diagnosis of AP. Therefore, this is the main limitation of the
applicability of our results on CTSI. The result of the risk of bias
and applicability assessment is showed in Tables 5A,B.
DISCUSSION
Summary of Main Findings
Severe acute pancreatitis is a serious state with highmortality and
it requires high costs of the health care system. By more accurate
prediction of the severity on admission, the risk of mortality can
be reduced with the immediate optimal therapy.
Acute pancreatitis is diagnosed on the basis of the presence
of two or more of the following three criteria: abdominal pain
consistent with the diagnosis elevated pancreatic enzymes to
a level of more than three times the upper normal value,
and characteristic findings on abdominal imaging. Different
radiological modalities (ultrasound, CT) are not only necessary
to make the diagnosis of AP, but by the visualization of the
gallbladder and biliary tract, they can reveal its etiology as biliary
or non-biliary. Furthermore, by using morphological scoring
systems e.g., CTSI or mCTSI, obtaining a CT scan can be useful
for assessing the severity of AP.
This is the first meta-analysis, which quantifies the accuracy
of CTSI and mCTSI scores for the prediction of the severity and
mortality of AP, and compares them with other commonly used
scoring systems. Two previous meta-analyses (Gao et al., 2015;
Yang and Li, 2016) assessed the predictive accuracy of the BISAP
score, but these articles did not contain CTSI nor mCTSI. Yang
and Li (2016) found that the pooled sensitivity and specificity of
the BISAP for the prediction of SAP were 0.65 (CI: 0.54–0.74)
and 0.84 (CI: 0.70–0.92), respectively, the pooled AUC was 0.77
(CI: 0.73–0.80). Gao et al. (2015) calculated the pooled sensitivity
as 0.51 (CI: 0.43–0.60), the specificity as 0.91 (CI: 0.89–0.92),
the AUC was 0.87. Based on our results, we calculated 0.73 (CI:
0.53–0.87) for sensitivity, 0.80 (CI: 0.72–0.88) for specificity, and
our pooled AUC was 0.79. The results are similar, the difference
in specificity between our results and those of Gao et al. (2015)
may be explained by the higher numbers of articles included in
our analysis.
In our meta-analysis, APACHE II proved to be the most
accurate scoring system for the prediction of mortality. It is
the most widely used mortality prediction score in critically ill
patients, however, it contains 12 points, including numerous
clinical parameters, hence its application can be cumbersome and
it limits its widespread use. In addition, APACHE II is designed
for patients admitted to the intensive care unit, therefore it is not
suitable for the early prediction of severity of AP. The AUC’s of
BISAP, mCTSI, and Ranson scores overlapped with APACHE II,
while those of CTSI and CRP were mildly weaker.
Computed tomography severity index is accurate to predict
severity, and its accuracy did not differ from the other
scoring systems. However, the Ranson, APACHE II, and BISAP
scores include several clinical parameters. There is a good
correlation between morphological severity according to CT
scoring systems and clinical scoring systems using clinical data
and laboratory parameters.
The most recent guidelines of AP recommend a CT scan 72–
96 h after the onset of the symptoms (Working Group IAP/APA
Acute Pancreatitis Guidelines., 2013; Hritz et al., 2015), because
pancreatic parenchymal necrosis in contrast-enhanced CT rarely
appears within 48 h (Ryu, 2009). The guidelines allow an earlier
CT scan in case of diagnostic uncertainty.
However, the contrast-enhanced CT examination cannot
always be performed in every patient. In extreme obese
patients, body weight, and size preclude the CT investigation.
The contrast-enhanced CT assessment requires an intravenous
injection of iodinated contrast medium for the detection
of hypoperfused areas in pancreas parenchyma, therefore
intravenous contrast media allergy, impaired renal function, and
hyperthyroidism are contraindications.
Because of the risk of radiation exposure, repeated CT scans
should be avoided, and should be reserved for patients who fail
to improve clinically. CT examination had shown an advantage
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TABLE 5A | The PROBAST Tool for mortality.
Study Risk of bias Applicability concerns Overall
Partici-
pants
Predictors Outcome
mortality
Ana-
lysis
Partici-
pants
Predictors Outcome
mortality
Risk of
bias
Appli-
cability
CTSI BISAP MCTSI CRP Ran-
son
Apache
II
CTSI BISAP MCTSI CRP Ran-
son
Apache
II
Biberoglu et al.,
2017
+ ? N/A N/A N/A N/A N/A – – – ? N/A N/A N/A N/A N/A – + ?
Bollen et al., 2011 – – N/A – N/A N/A ? – – – + N/A + N/A N/A ? – – +
Sharma et al.,
2015
– – – – N/A N/A N/A N/A – – + ? + N/A N/A N/A N/A – +
Yang et al., 2016 – N/A – – N/A – – – ? + N/A – – N/A – – – – +
Bollen et al., 2012 – – – – N/A N/A – – – – + – – N/A N/A – – – +
Alper et al., 2016 + – N/A N/A N/A N/A N/A – – + – N/A N/A N/A N/A N/A – + –
Simchuk et al.,
2000
– ? N/A N/A N/A N/A N/A – – – ? N/A N/A N/A N/A N/A N/A ? ?
Jakchairoongruang
and Arjhansiri,
2013
– ? N/A N/A N/A N/A N/A – + + ? N/A N/A N/A N/A N/A – + +
Park et al., 2013 – – – N/A – – – – – – + – N/A – – – – – +
Khanna et al.,
2013
– + – N/A + – – – – – – N/A N/A – – – – + –
Yadav et al., 2016 + – – N/A N/A – N/A – – – + – N/A N/A – N/A – + +
Papachristou
et al., 2010
– + – N/A N/A – – – – – + – N/A N/A – – – + +
Vriens et al., 2005 – – N/A N/A N/A – N/A N/A + – + N/A N/A N/A – N/A – – +
Raghuwanshi
et al., 2016
+ ? N/A ? N/A N/A N/A – ? ? + N/A + N/A N/A N/A – + +
Banday et al.,
2015
– N/A N/A ? N/A N/A N/A – ? – N/A N/A + N/A N/A N/A – ? +
Sahu et al., 2017 – – N/A – N/A N/A N/A – ? – + N/A + N/A N/A N/A – ? +
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TABLE 5B | The PROBAST Tool for severity.
Study Risk of bias Applicability concerns Overall
Partici-
pants
Predictors Outcome
severity
Ana-
lysis
Partici-
pants
Predictors Outcome
severity
Risk of
bias
Appli-
cability
CTSI BISAP MCTSI CRP Ran-
son
Apache
II
CTSI BISAP MCTSI CRP Ran-
son
Apache
II
Cho et al., 2015 – – – N/A – – – – – – – – N/A – – – – – –
Gurleyik et al.,
2005
– – N/A N/A – N/A – – – – + N/A N/A – N/A – – – +
Lee et al., 2016 – – – N/A – – – – ? – + – N/A – – – – ? +
Qiu et al., 2015 – – – N/A N/A – N/A – – – – – N/A N/A – N/A – – –
Yue et al., 2015 – + N/A N/A N/A – – – – – + N/A N/A N/A – – – + +
Bollen et al., 2011 – – N/A – N/A N/A ? – – – + N/A + N/A N/A ? – – +
Yang et al., 2016 – N/A – – N/A – – – ? + N/A – – N/A – – – – +
Bollen et al., 2012 – – – – N/A N/A – – – – + – – N/A N/A – – – +
Alper et al., 2016 – – N/A N/A N/A N/A N/A + – + – N/A N/A N/A N/A N/A – + +
Zhao et al., 2016 – – N/A N/A – N/A – – – + – N/A N/A – N/A – – – +
Fabre et al., 2012 – + N/A N/A N/A – N/A – ? + N/A N/A N/A N/A ? N/A – + +
Hashimoto et al.,
2016
– ? N/A N/A N/A ? N/A N/A + + ? N/A N/A N/A ? N/A ? + +
Park et al., 2013 – – – N/A – – – – – – + – N/A – – – – – +
Khanna et al.,
2013
– + – N/A + – – – – – – N/A N/A – – – – + –
Lautz et al., 2012 + – N/A N/A N/A ? N/A – ? + + N/A N/A N/A ? N/A N/A + +
Chatzicostas
et al., 2003
– – N/A N/A N/A – – – ? – – N/A N/A N/A – – – – –
Xu et al., 2014 + – N/A N/A N/A N/A N/A – – – – N/A N/A N/A N/A N/A – + –
Yadav et al., 2016 + – – N/A N/A – N/A – – – + – N/A N/A – N/A – + +
Papachristou
et al., 2010
– + – N/A N/A – – – – – + – N/A N/A – – – + +
Huang et al., 2010 – – N/A N/A N/A N/A N/A – – – + N/A N/A N/A N/A N/A – – +
Fei et al., 2018 – ? – N/A N/A – – – – – + – N/A N/A – – – ? +
Kumar et al., 2017 – ? N/A N/A – – N/A ? – – – N/A N/A – – N/A – ? –
red, high risk of bias or concern; yellow, unclear risk of bias or concern; green, low risk of bias or concern; +, high risk of bias or concern; ?, unclear risk of bias or concern; −, low risk of bias or concern.
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FIGURE 4 | (A) Hierarchial summary receiver operating characteristic curves (HSROC) for computed tomography severity index (CTSI) for predicting mortality of acute
pancreatitis. (B) HSROC for CTSI for predicting severity of acute pancreatitis.
FIGURE 5 | (A) Hierarchial summary receiver operating characteristic curves (HSROC) for bedside index of severity in acute pancreatitis (BISAP) for predicting
mortality. (B) HSROC for BISAP for predicting severity of acute pancreatitis.
in evaluation of local complications (Ju et al., 2006), which can
modify therapeutical strategy.
Contrary to the evaluation of Ranson, BISAP, and APACHE II
scores, contrast-enhanced CT assessment, and CTSI calculation
require radiological expertise.
Limitations
Three of the articles contained data of children (Fabre et al.,
2012; Lautz et al., 2012; Hashimoto et al., 2016), in 2 from these
articles the DeBanto score was used for evaluating the severity
of AP, which is a specific score for pediatric pancreatitis. The AP
population of the studies is not necessarily representative for the
whole AP population, because the CT scan is mostly performed
in the more severe cases. In several studies not all etiologies
of AP were included, Yang et al. included only patients with
hyperlipidemic etiology while Alper et his coworkers included
only biliary AP cases. Fifteen of the included studies were
retrospectively designed, and these might have caused selection
bias. The time of CTSI and mCTSI was not the same in the
studies, in several studies it included a longer delay, while
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FIGURE 6 | (A) Hierarchial summary receiver operating characteristic curves (HSROC) for modified computed tomography severity index (mCTSI) for predicting
mortality of acute pancreatitis. (B) HSROC for mCTSI for predicting severity of acute pancreatitis.
in others it was carried out on admission, leading to higher
heterogeneity. While APACHE II, Ranson, BISAP and CRP
values were established mostly on admission or within the first
48 h, the optimal timing of the CT examination 72–96 h after the
onset of the symptoms and in several studies it was performed
later than the other prognostic scores. This can limitate the
prognostic score of the CTSI because the other scores can predict
earlier severity or mortality with similar accuracy. It is also a
good question if the radiologist can judge the time point of
necrosis development. In populations with previous necrotizing
pancreatitis, the severity cannot be accurately assessed.
For the value of predicting mortality, a considerable
heterogeneity for CTSI and a substantial heterogeneity for
Ranson score can be observed, while for the severity predicting
value of AP a considerable heterogeneity for CTSI, BISAP,
CRP, and Ranson scores and substantial heterogeneity for
mCTSI can be noticed. We suspect that the confounder
factors, that cause high heterogeneity among the studies
are because of different population in terms of ethnicity,
BMI, age (etc.), and etiology, the different timing and
interpretation of imagingmodalities, and potential inter observer
variability between the radiologists interpreting the CT images.
Because of the long delay characterizing the studies, the
severity was assessed according to several Atlanta classifications
and definitions.
CONCLUSIONS
Implications for Practice
In the prediction of mortality in AP, CTSI was revealed as
equally valuable as BISAP, mCTSI, CRP, or Ranson score, only
APACHE II score overcame its predicting ability. Considering
severity, there was no difference in the prediction value of the
FIGURE 7 | Hierarchial summary receiver operating characteristic curves
(HSROC) for C-reactive protein (CRP) for predicting severity of acute
pancreatitis.
scores. If CT scans are performed, CTSI and mCTSI can be
easily calculated and should be used in addition to the other
scoring systems.
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FIGURE 8 | (A) Hierarchial summary receiver operating characteristic curves (HSROC) for Ranson score for predicting mortality of acute pancreatitis. (B) HSROC for
Ranson score for predicting severity of acute pancreatitis.
FIGURE 9 | (A) Hierarchial summary receiver operating characteristic curves (HSROC) for Acute Physiology And Chronic Health Examination II (APACHE II) score for
predicting mortality of acute pancreatitis. (B) HSROC for APACHE II score for predicting severity of acute pancreatitis.
Implications for Research
Further research is warranted for the assessment
of the effect of early CT and its predictive value
in AP.
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